181 related articles for article (PubMed ID: 22610453)
1. Presence versus absence of hydrogen bond donor Tyr-39 influences interactions of cationic trypsin and mesotrypsin with protein protease inhibitors.
Salameh MA; Soares AS; Alloy A; Radisky ES
Protein Sci; 2012 Aug; 21(8):1103-12. PubMed ID: 22610453
[TBL] [Abstract][Full Text] [Related]
2. Mesotrypsin Has Evolved Four Unique Residues to Cleave Trypsin Inhibitors as Substrates.
Alloy AP; Kayode O; Wang R; Hockla A; Soares AS; Radisky ES
J Biol Chem; 2015 Aug; 290(35):21523-35. PubMed ID: 26175157
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin.
Salameh MA; Soares AS; Hockla A; Radisky ES
J Biol Chem; 2008 Feb; 283(7):4115-23. PubMed ID: 18077447
[TBL] [Abstract][Full Text] [Related]
4. Determinants of affinity and proteolytic stability in interactions of Kunitz family protease inhibitors with mesotrypsin.
Salameh MA; Soares AS; Navaneetham D; Sinha D; Walsh PN; Radisky ES
J Biol Chem; 2010 Nov; 285(47):36884-96. PubMed ID: 20861008
[TBL] [Abstract][Full Text] [Related]
5. The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.
Salameh MA; Soares AS; Hockla A; Radisky DC; Radisky ES
Biochem J; 2011 Nov; 440(1):95-105. PubMed ID: 21806544
[TBL] [Abstract][Full Text] [Related]
6. Sequence and conformational specificity in substrate recognition: several human Kunitz protease inhibitor domains are specific substrates of mesotrypsin.
Pendlebury D; Wang R; Henin RD; Hockla A; Soares AS; Madden BJ; Kazanov MD; Radisky ES
J Biol Chem; 2014 Nov; 289(47):32783-97. PubMed ID: 25301953
[TBL] [Abstract][Full Text] [Related]
7. Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin.
Cohen I; Coban M; Shahar A; Sankaran B; Hockla A; Lacham S; Caulfield TR; Radisky ES; Papo N
J Biol Chem; 2019 Mar; 294(13):5105-5120. PubMed ID: 30700553
[TBL] [Abstract][Full Text] [Related]
8. The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin.
Salameh MA; Robinson JL; Navaneetham D; Sinha D; Madden BJ; Walsh PN; Radisky ES
J Biol Chem; 2010 Jan; 285(3):1939-49. PubMed ID: 19920152
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
Scheidig AJ; Hynes TR; Pelletier LA; Wells JA; Kossiakoff AA
Protein Sci; 1997 Sep; 6(9):1806-24. PubMed ID: 9300481
[TBL] [Abstract][Full Text] [Related]
10. Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor.
Zakharova E; Horvath MP; Goldenberg DP
J Mol Biol; 2008 Oct; 382(4):998-1013. PubMed ID: 18692070
[TBL] [Abstract][Full Text] [Related]
11. Human mesotrypsin exhibits restricted S1' subsite specificity with a strong preference for small polar side chains.
Szepessy E; Sahin-Tóth M
FEBS J; 2006 Jul; 273(13):2942-54. PubMed ID: 16759229
[TBL] [Abstract][Full Text] [Related]
12. Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis.
Szabó A; Ludwig M; Hegyi E; Szépeová R; Witt H; Sahin-Tóth M
J Biol Chem; 2015 Jul; 290(28):17282-92. PubMed ID: 26013824
[TBL] [Abstract][Full Text] [Related]
13. Effect of pea and bovine trypsin inhibitors on wild-type and modified trypsins.
Pouvreau L; Chobert JM; Briand L; Quillien L; Tran V; Guéguen J; Haertlé T
FEBS Lett; 1998 Feb; 423(2):167-72. PubMed ID: 9512351
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI.
Perona JJ; Tsu CA; Craik CS; Fletterick RJ
J Mol Biol; 1993 Apr; 230(3):919-33. PubMed ID: 7683059
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of mesotrypsin from a structure-based docking screen.
Kayode O; Huang Z; Soares AS; Caulfield TR; Dong Z; Bode AM; Radisky ES
PLoS One; 2017; 12(5):e0176694. PubMed ID: 28463992
[TBL] [Abstract][Full Text] [Related]
16. Identification and expression of the cDNA-encoding human mesotrypsin(ogen), an isoform of trypsin with inhibitor resistance.
Nyaruhucha CN; Kito M; Fukuoka SI
J Biol Chem; 1997 Apr; 272(16):10573-8. PubMed ID: 9099703
[TBL] [Abstract][Full Text] [Related]
17. Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors.
Szmola R; Kukor Z; Sahin-Tóth M
J Biol Chem; 2003 Dec; 278(49):48580-9. PubMed ID: 14507909
[TBL] [Abstract][Full Text] [Related]
18. Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1.
de Veer SJ; Li CY; Swedberg JE; Schroeder CI; Craik DJ
Eur J Med Chem; 2018 Jul; 155():695-704. PubMed ID: 29936356
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation.
Toldi V; Szabó A; Sahin-Tóth M
J Biol Chem; 2020 Mar; 295(11):3447-3455. PubMed ID: 32014997
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine sulfation of human trypsin steers S2' subsite selectivity towards basic amino acids.
Szabó A; Salameh MA; Ludwig M; Radisky ES; Sahin-Tóth M
PLoS One; 2014; 9(7):e102063. PubMed ID: 25010489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
